Minimally Invasive Neurosurgical Devices Market Report 2025

The minimally invasive neurosurgical devices market size has grown strongly in recent years. It will grow from $2.82 billion in 2024 to $3.04 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth during the historic period can be attributed to the rising adoption of stereotactic surgical techniques, increased use of intraoperative magnetic resonance imaging systems, a growing number of neurosurgical training programs, expanded deployment of endoscopic systems in cranial procedures, and increasing awareness among neurosurgeons regarding minimally invasive approaches.

The minimally invasive neurosurgical devices market size is expected to see strong growth in the next few years. It will grow to $4.03 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to the increasing demand for robot-assisted neurosurgical procedures, rising incidence of brain tumors and spinal disorders, growing medical tourism for neurosurgical treatments, increasing acceptance of ambulatory surgical centers, and a heightened focus on patient-centric and precision surgery. Major trends during the forecast period include the development of smart endoscopic tools with real-time feedback, the creation of flexible micro-instruments for deep brain access, innovation in biocompatible materials for neuro-implants, advancements in laser ablation techniques for tumor removal, and the development of flexible catheter-based tools.

The rising prevalence of neurological disorders is expected to drive the growth of the minimally invasive neurosurgical devices market in the coming years. Neurological disorders are medical conditions that affect the brain, spinal cord, or nerves, causing issues related to movement, sensation, behavior, or cognition. This increase in neurological disorders is largely attributed to lifestyle factors such as unhealthy diets, physical inactivity, chronic stress, and prolonged exposure to environmental toxins, all of which negatively affect brain health over time. Minimally invasive neurosurgical devices support the treatment of these conditions by allowing for precise, less invasive procedures that shorten recovery times, reduce the risk of complications, and improve patient outcomes. For example, in March 2023, the Alzheimer’s Association, a US-based nonprofit health organization, reported that approximately 6.7 million Americans aged 65 and older were living with Alzheimer’s dementia in 2023, with projections rising to 13.8 million by 2060. As a result, the growing prevalence of neurological disorders is contributing to the expansion of the minimally invasive neurosurgical devices market.

Leading companies in the minimally invasive neurosurgical devices market are prioritizing the development of advanced technologies, such as image-guided therapy systems, to increase precision and safety during complex neurological procedures. These systems utilize real-time imaging to assist surgeons in accurately navigating and treating specific areas of the brain during minimally invasive interventions. For instance, in February 2024, Koninklijke Philips N.V., a Netherlands-based health technology company, introduced the Azurion neuro biplane system. This cutting-edge platform is designed to improve the diagnosis and treatment of neurovascular conditions by offering high-quality 2D and 3D imaging, adaptable X-ray detector positioning, and complete table-side control. It also includes enhanced C-arm rotation and angulation for efficient imaging transitions, automatic beam rotation for properly aligned images, a new stroke-specific head immobilizer, and AI-powered remote monitoring to optimize system availability.

In September 2024, Stryker Corporation, a US-based medical technology company, acquired NICO Corporation for an undisclosed sum. Through this acquisition, Stryker aims to broaden its minimally invasive neurotechnology portfolio, enhancing its ability to deliver better outcomes in brain tumor removal and the treatment of intracerebral hemorrhage. NICO Corporation is a US-based firm specializing in minimally invasive neurosurgical devices.

Major players in the minimally invasive neurosurgical devices market are Medtronic Plc, Fujifilm Holdings Corporation, Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, Zimmer Biomet Holdings Inc., Olympus Corporation, Karl Storz GmbH And Co. KG, Integra LifeSciences Holdings Corporation, Elekta AB, Applied Medical Resources Corporation, Penumbra Inc., KLS Martin Group, B. Braun Melsungen AG, Ackermann Instrumente GmbH, Scanlan International Inc., OmniGuide Holdings Inc., Biolitec AG, Adeor Medical AG, and Vycor Medical Inc.

North America was the largest region in the minimally invasive neurosurgical devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in minimally invasive neurosurgical devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the minimally invasive neurosurgical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The minimally invasive neurosurgical devices market consists of revenues earned by entities by providing services such as image-guided surgical navigation, robotic-assisted neurosurgery solutions, intraoperative monitoring services, customized surgical toolkits and implants, and maintenance and technical support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The minimally invasive neurosurgical devices market also includes sales of ablation devices, retractor systems, external video monitors, biopsy needles and cannulas, and ultrasonic aspirators. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The minimally invasive neurosurgical devices market research report is one of a series of new reports that provides minimally invasive neurosurgical devices market statistics, including minimally invasive neurosurgical devices global market size, regional shares, competitors with minimally invasive neurosurgical devices market share, detailed minimally invasive neurosurgical devices market segments, market trends and opportunities, and any further data you may need to thrive in the minimally invasive neurosurgical devices industry. The minimally invasive neurosurgical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Minimally invasive neurosurgical devices are specialized medical tools and technologies designed to carry out neurosurgical procedures through small incisions or natural body openings, minimizing harm to surrounding tissues. These devices offer enhanced precision, faster recovery times, and lower surgical risks compared to conventional open brain or spinal surgeries.

The primary product types of minimally invasive neurosurgical devices include miniature video cameras, fiber optic cables, external video monitors, and specialized surgical instruments. Miniature video cameras are compact imaging devices designed to capture video in confined or hard-to-access areas and are commonly used in medical, surveillance, or industrial contexts. These devices incorporate advanced technologies such as image-guided surgery, robotic surgery, navigation systems, optical coherence tomography, and endoscopic techniques. They are used across various surgical specialties, including urological, vascular, cardiac, breast, orthopedic, gynecological, gastrointestinal, cosmetic, bariatric, and thoracic surgeries. Applications include brain tumor resection, spinal surgery, aneurysm repair, epilepsy surgery, and trauma or fracture repair. End users include hospitals, ambulatory surgical centers, neurology clinics, research institutions, and outpatient surgical centers.

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.